These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17166448)

  • 41. [Karyotypic analysis and prognosis for 41 patients with chronic myelomonocytic leukemia].
    Lu Y; Yu MX; Mu QT; Wang Q; Chen ZM; Lou JY; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):134-7. PubMed ID: 23568720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cytogenetic study of 93 myelodysplastic syndromes].
    Solé F; Woessner S; Florensa L; Pérez-Losada A; Acín P; Besses C; García-Eroles L; Sans-Sabrafen J
    Med Clin (Barc); 1998 Jan; 110(3):94-8. PubMed ID: 9534140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia.
    Bochtler T; Stölzel F; Heilig CE; Kunz C; Mohr B; Jauch A; Janssen JW; Kramer M; Benner A; Bornhäuser M; Ho AD; Ehninger G; Schaich M; Krämer A
    J Clin Oncol; 2013 Nov; 31(31):3898-905. PubMed ID: 24062393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
    Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
    Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical study of Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Bao L; Jiang B; Huang XJ; Wang DB; Qiu JY; Lu XJ; Chen H; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):31-4. PubMed ID: 15946506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
    Kebriaei P; Kline J; Stock W; Kasza K; Le Beau MM; Larson RA; van Besien K
    Bone Marrow Transplant; 2005 May; 35(10):965-70. PubMed ID: 15806131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.
    Kantarjian HM; Keating MJ; Walters RS; Smith TL; Cork A; McCredie KB; Freireich EJ
    J Clin Oncol; 1986 Dec; 4(12):1748-57. PubMed ID: 3783201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.
    Batzios C; Hayes LA; He SZ; Quach H; McQuilten ZK; Wall M; Campbell LJ
    Am J Hematol; 2009 Nov; 84(11):715-9. PubMed ID: 19806661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathological evolution and multilineage involvement in erythroleukemia: report of a case.
    Cuneo A; Gretel Carli M; Piva N; Fagioli F; Vandenberghe E; Dal Cin P; Castoldi G; Van Den Berghe H
    Haematologica; 1991; 76(3):235-7. PubMed ID: 1743594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
    Davey FR; Abraham N; Brunetto VL; MacCallum JM; Nelson DA; Ball ED; Griffin JD; Baer MR; Wurster-Hill D; Mayer RJ
    Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia.
    Olopade OI; Thangavelu M; Larson RA; Mick R; Kowal-Vern A; Schumacher HR; Le Beau MM; Vardiman JW; Rowley JD
    Blood; 1992 Dec; 80(11):2873-82. PubMed ID: 1450412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia.
    Bochtler T; Granzow M; Stölzel F; Kunz C; Mohr B; Kartal-Kaess M; Hinderhofer K; Heilig CE; Kramer M; Thiede C; Endris V; Kirchner M; Stenzinger A; Benner A; Bornhäuser M; Ehninger G; Ho AD; Jauch A; Krämer A;
    Blood; 2017 Mar; 129(10):1333-1342. PubMed ID: 28119329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The importance of cytogenetic studies in adult acute lymphocytic leukemia.
    Walters R; Kantarjian HM; Keating MJ; Estey EH; Trujillo J; Cork A; McCredie KB; Freireich EJ
    Am J Med; 1990 Nov; 89(5):579-87. PubMed ID: 2239977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of cytogenetic abnormalities on the management of skull base chordomas.
    Almefty KK; Pravdenkova S; Sawyer J; Al-Mefty O
    J Neurosurg; 2009 Apr; 110(4):715-24. PubMed ID: 19133754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Study on cytogenetic changes with relation to FAB classification in 397 patients with acute leukemias].
    Huo FF; Liu X; Sun ZM; Zhu WB; Zheng CC; Wang J; Wu ZW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):6-10. PubMed ID: 21362211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.